Palisade Bio
September 06, 2023 - by Joey Ramson
$PALI more than doubled in price today and led the Prism MarketView Biotech index on news of a licensing agreement with Giiant Pharma. $PALI was up even more earlier in the day but snapped back to close right below its 50DMA
